From: Oxygenation strategies during flexible bronchoscopy: a review of the literature
Year | Patients enrolled | FOB performed | Study type | Clinical status | Setting | RS before FOB | RS during FOB | FOB purpose | Analgosedation strategy | Main outcomes | |
---|---|---|---|---|---|---|---|---|---|---|---|
Antonelli M., et al. [1] | 1996 | 8 | 8 | Interventional | Acute | ICU | COT | NPPV | Diagnostic | Lidocaine | O2 saturation, PaO2/FiO2, PaCO2, RR, HR, intubation, mortality |
Jones A.M., et al. [9] | 2000 | 1074 | 2261 | Observational | Chronic | Ward | None | COT | Diagnostic | Midazolam, lignocaine | O2 saturation |
Onakpoya U.U., et al. [10] | 2012 | 61 | 67 | Observational | Chronic | Ward | None | COT | Diagnostic | Diazepam, lignocaine | O2 saturation |
Golpe R., Mateos A. [11] | 2002 | 44 | 44 | Observational | ND | ND | None | COT | ND | Lignocaine | O2 saturation |
Alijanpour E., et al. [12] | 2010 | 146 | 146 | Observational | ND | ND | None | COT | ND | Lidocaine | O2 saturation |
Cracco C., et al. [13] | 2013 | 169 | 181 | Observational | Acute | ICU | COT, NPPV | COT, NPPV | Diagnostic, therapeutic | ND | Intubation, increased ventilatory support |
Ghio A.J., et al. [14] | 2007 | 12 | 12 | Prospective randomized | Healthy volunteers | Outpatients | COT or none | COT or none | Research | Lidocaine | O2 saturation |
McCain T.W., et al. [15] | 2001 | 97 | 97 | Prospective randomized | Chronic | ND | COT | COT | Diagnostic | Meperidine or fentanyl, midazolam | O2 saturation, O2 flow rate |
Miyagi K., et al. [16] | 2014 | 5 | 5 | Observational | Acute | ICU | COT | HFNC | Diagnostic | ND | O2 saturation |
La Combe B., et al. [17] | 2016 | 30 | 30 | Observational | Acute | ICU | COT | HFNC | Diagnostic | ND | O2 saturation, dyspnea, intubation, mortality |
Longhini F., et al. [18] | 2021 | 36 | 36 | Prospective randomized | Chronic | Outpatients | None | COT or HFNC | Diagnostic | Lidocaine | O2 saturation, PaO2, ΔEELI, DD, TF |
Chung S.M., et al. [19] | 2018 | 10 | 10 | Observational | Acute, chronic | Ward | COT | HFNC | Diagnostic, therapeutic | Midazolam, propofol, lidocaine | O2 saturation |
Service J.A., et al. [20] | 2018 | 182 | 182 | Observational | Chronic | Outpatients | None | HFNC | Diagnostic | Remifentanil. propofol or midazolam | O2 saturation |
Ben-Menachem E., et al. [21] | 2020 | 76 | 76 | Prospective randomized | Chronic | Ward | None | COT or HFNC | Diagnostic | ND | O2 saturation |
Lucangelo U. et al. [22] | 2012 | 45 | 45 | Prospective randomized | Acute, chronic | Ward | None | COT or HFNC | Diagnostic | Midazolam, lidocaine | O2 saturation, PaO2, PaO2/FiO2 |
Irfan M., et al. [23] | 2021 | 40 | 40 | Prospective randomized | Chronic | Ward | None | COT or HFNC | Diagnostic | ND | O2 saturation |
Douglas N., et al. [24] | 2018 | 60 | 60 | Prospective randomized | Chronic | ND | None | COT or HFNC | Diagnostic | Midazolam, opioids and/or propofol, lidocaine | O2 saturation |
Kim E.J., et al. [25] | 2018 | 32 | 33 | Observational | Acute | Ward | COT or HFNC | HFNC | Diagnostic | Midazolam, lidocaine | O2 saturation PaO2/FiO2 |
Maitre B., et al. [26] | 2000 | 30 | 30 | Prospective randomized | Acute | Ward, ICU | COT | COT or CPAP | Diagnostic | Lidocaine | O2 saturation, PaO2, ventilatory assistance requirement |
Antonelli M., et al. [27] | 2002 | 26 | 26 | Prospective randomized | Acute | ICU | COT | COT or NPPV | Diagnostic | Lidocaine | PaO2/FiO2, HR, MAP, intubation |
Baumann H.J., et al. [28] | 2011 | 40 | 40 | Observational | Acute | ICU | NIV | NIV | Diagnostic, therapeutic | Midazolam, propofol, lidocaine | O2 saturation, PaO2/FiO2, PaCO2, intubation |
Korkmaz Ekren P., et al. [29] | 2016 | 28 | 28 | Observational | Acute | ICU | NIV | NIV | Diagnostic, therapeutic | Midazolam, lidocaine | PaO2/FiO2, intubation |
Chiner E., et al. [30] | 2010 | 35 | 35 | Observational | Acute | Ward, ICU | NIPPV | NIPPV | Diagnostic, therapeutic | Lidocaine | O2 saturation, RR, HR, intubation, mortality |
Heunks L.M.A., et al. [31] | 2010 | 12 | 12 | Observational | Acute | ICU | COT | NPPV | Diagnostic | Xylocaine | O2 saturation, PaO2/FiO2, intubation |
Antonelli M., et al. [32] | 2003 | 4 | 4 | Interventional | Acute | ICU | COT | NPPV | Diagnostic | Lidocaine | O2 saturation, PaO2/FiO2, PaCO2, RR, HR, MAP, intubation |
Agarwal R., et al. [33] | 2012 | 6 | 6 | Observational | Acute | Ward | COT | NIV | Diagnostic, therapeutic | Lidocaine | O2 saturation, PaO2/FiO2, intubation |
Chen X., et al. [34] | 2020 | 29 | 29 | Retrospective | Acute | Ward | COT | NIV, CMV | Therapeutic | Dezocine, midazolam, lidocaine | O2 saturation, PaO2, HR, SBP, type of procedures, success rate, procedure time |
Da Conceiçao M., et al. [35] | 2000 | 10 | 10 | Prospective | Acute | ICU | None | NIPPV | Diagnostic | Lidocaine | O2 saturation, PaO2, PaCO2, intubation, mortality |
Mohamed A.S., El-Sharawy D.E. [36] | 2018 | 40 | 20 | Prospective randomized | Acute | Ward | NIV | NIV | Therapeutic | Midazolam, lidocaine | O2 saturation |
Scala R., et al. [37] | 2010 | 30 | 30 | Prospective | Acute | RICU, ICU | NPPV | NPPV, CMV | Diagnostic | Lidocaine | O2 saturation, PaO2/FiO2, PaCO2, pH |
Simon M., et al. [38] | 2014 | 40 | 40 | Prospective randomized | Acute | ICU | COT | NIV or HFNC | Diagnostic, therapeutic | Propofol, lidocaine | O2 saturation, PaO2/FiO2, PaCO2, HR, MAP, procedure time, intubation, mortality |
Saksitthichok B., et al. [39] | 2019 | 51 | 51 | Prospective randomized | Acute | Ward or RICU | NIV or HFNC | NIV or HFNC | Diagnostic | Fentanyl, lidocaine | O2 saturation, PaO2, PaCO2, pH, RR, HR, MAP, dyspnea |